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a b s t r a c t
Cranial cartilage derives mainly from cranial neural crest cells and its formation requires ﬁbroblast
growth factor (Fgf) signaling for early differentiation and survival of developing chondrocytes as well as
patterning of the endodermal pouches.
Here, we investigate the role of Fgf receptors in chondrocyte maturation at later stages, beyond
24 hpf. Using inducible expression of a dominant-negative Fgf receptor, we show that Fgf signaling is
required around 30 hpf for correct cartilage formation. The receptor genes fgfr1a and fgr2 are expressed
in pharyngeal endodermal pouches after 24 hpf or 26 hpf, respectively. Depletion of any of these two
receptors by microinjection of antisense morpholinos results in severe defects in cartilage formation at
4 dpf and a decrease in expression of the late chondrocyte markers barx1 and runx2b. Although
endodermal pouches are correctly formed and patterned, receptor knock down leads to decreased
expression of runx3, egr1 and sox9b in this tissue, while expression of fsta, coding for a secreted BMP/Tgfß
inhibitor, is clearly increased. Rescue experiments revealed that each Fgfr1a or Fgfr2 receptor is able to
compensate for the loss of the other.
Thus, we show that minimal amounts of Fgfr1a or Fgfr2 are required to initiate a regulatory cascade
in pharyngeal endoderm reducing expression of fsta, thereby allowing correct BMP signaling to the
maturing chondrocytes of the head cartilage.
& 2013 Published by Elsevier B.V. on behalf of International Society of Differentiation
1. Introduction
Craniofacial bone structures result from both membranous and
endochondral or perichondral ossiﬁcation, the latter requiring pre-
liminary formation of a cartilaginous matrix. Pharyngeal cartilages
derive frommigration and differentiation of cranial neural crest cells
(cNCC) within the pharyngeal arches. These cNCCs are formed at the
neurulation stage and migrate in three streams into the seven
pharyngeal pouches to form the different cartilage elements of the
viscerocranium (mandible, hyoid, ﬁve ceratobranchial arches)
(Schilling and Kimmel, 1994; Knight and Schilling, 2006). During
and after this migration, the cNCCs undergo several differentiation
steps to ﬁnally give rise to hypertrophic chondrocytes and osteo-
genic cells. After initial expression of tfap2a characteristic to all cNCC
cells (Barrallo-Gimeno et al., 2004), ectomesenchymal cartilage
precursors are identiﬁed by early expression of dlx2a (Sperber
et al., 2008) while chondrogenic differentiation is characterized by
the onset of sox9a expression required for production of the
cartilage-speciﬁc collagen Col2a1 (Kluver et al., 2005; Yan et al.,
2005). Finally, maturing hypertrophic chondrocytes express runx2b
(Flores et al., 2008; Flores et al., 2004), a marker that is also present
in bone-forming osteoblasts.
In the arches, the cNCCs are surrounded by and interact with
different tissues such as pharyngeal endoderm and ectodermal
epithelium. In casanova (cas) mutant zebraﬁsh, endoderm is
lacking (Alexander et al., 1999) and pharyngeal cartilages are not
formed (David et al., 2002). Loss of function of several genes
expressed in pharyngeal endoderm, such as egr1, runx3 or sox9b
leads to severe reduction of head cartilage Q3at 4 dpf (Dalcq et al., in
press; Kluver et al., 2005; Yan et al., 2005; Flores et al., 2006).
Thus, interaction between endoderm and cNCCs is primordial for
the correct formation of pharyngeal cartilage (Crump et al., 2004;
Piotrowski and Nusslein-Volhard, 2000; Schilling et al., 1996)
involving signaling pathways initiated by Bmp, Fgf or Hh ligands
(Goldring et al., 2006; Walshe and Mason, 2003). Recently, BMP
signaling was shown to be required for early ventral arch devel-
opment, upstream and simultaneously to endothelin1 (Edn1)
(Alexander et al., 2011). An additional role for craniofacial pattern-
ing at later stages was also shown. We recently showed the
existence of a regulatory cascade formed by the three transcription
factors Runx3–Egr1–Sox9b, each being required for expression of
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This cascade controls late chondrogenesis by down-regulating
expression of Follistatin A (fsta), a known antagonist of BMP
signaling, thereby allowing correct activation of the BMP
pathway required to activate runx2b expression in developing
chondrocytes.
Fibroblast growth factor (Fgf) signaling is involved in prolifera-
tion, migration and speciﬁcation of many cell types (Ornitz and
Itoh, 2001; Walshe and Mason, 2003; Thisse and Thisse, 2005). It is
highly conserved across different species (Itoh, 2007; Itoh and
Ornitz, 2008) and is initiated by numerous Fgf ligands binding
speciﬁc tyrosine kinase (RTK) receptors (Fgfrs). In mice, Fgf9
controls early hypertrophic chondrocyte differentiation (Hung
et al., 2007) while in zebraﬁsh, Fgf3 and Fgf8 are produced in
pharyngeal endoderm and ectoderm and control segmentation of
the pharyngeal endoderm and survival of cNCCs (Crump et al.,
2004; David et al., 2002; Walshe and Mason, 2003). Five genes for
Fgfrs have been identiﬁed: Fgfr1-4 (RTK) and Fgfr5/Fgfrl1. In Fgfrl1,
the tyrosine kinase domain is replaced by a phosphatase domain:
it thus acts as a negative regulator of Fgf signaling (Hall et al.,
2006) and is also important for craniofacial cartilage formation
(Hall et al., 2006; Trueb and Taeschler, 2006). In humans, muta-
tions in Fgfrs, causing either increased or decreased Fgf signaling,
generate craniofacial malformations resulting from deﬁcient chon-
drogenesis (e.g. Apert syndrome, Crouzon syndrome, Pfeiffer
syndrome, Kallmann syndrome 2, Jackson–Weiss syndrome)
(Nie et al., 2006; Baldridge et al., 2010). In mice, fgfr1 controls
endoderm patterning in the pharyngeal region and plays a crucial
role in cNCC migration into the branchial arches (Trokovic et al.,
2003). Different studies in zebraﬁsh have shown that inhibition of
Fgfr signaling by SU5402 generates embryos lacking pharyngeal
cartilage at 4 days post fertilization (dpf) and down-regulates
expression of genes known to be crucial for chondrogenesis
(Walshe and Mason, 2003; Sperber et al., 2008).
In zebraﬁsh, the role of Fgf signaling in head cartilage forma-
tion was mainly studied by blocking the pathway at very early
stages and thus possibly affecting multiple functions of this
versatile signaling during early development. Here, we used
heat-shock controlled expression of a dominant-negative Fgf
receptor in Tg(hsp70l:dnfgfr1-EGFP)pd1 transgenic embryos to
show a critical stage for Fgfr activities in chondrogenesis around
30 hpf. We also show that fgfr1a and fgfr2 are both expressed in
pharyngeal endoderm at this stage and we demonstrate that fgfr1a
or fgfr2 depletion speciﬁcally causes severe cartilage defects at
4 dpf, which can be rescued by concomitant expression of exo-
genous zebraﬁsh or human Fgf receptors. We further show that
these two receptors are required for activation of the Runx3–Egr1–
Sox9b–Fsta cascade in the endoderm and for runx2b expression in
developing chondrocytes. Finally, the defects in cartilage structure
and gene expression observed in morphants for each of the
receptors Fgfr1a or Fgfr2 can be rescued by ectopic expression of
each of the two receptors, indicating that the exact identity of the
receptor active in pharyngeal endoderm is not important, but
rather the precise number of receptor molecules.
2. Materials and methods
2.1. Zebraﬁsh maintenance and transgenic line
Adult zebraﬁsh (Danio rerio) and embryos were raised as
described (Westerﬁeld, 2007). Embryos were kept in E3 medium
at 28 1C and developed until the stages of interest according to
Kimmel et al. (1995). The transgenic lines Tg(hsp70l:dnfgfr1-EGFP)
pd1 (Lee et al., 2005) and Tg(sox17-GFP)s870 (Sakaguchi et al., 2006)
were obtained from the ZIRC (Eugene, Oregon, USA).
2.2. Ethics statement
All experiments and the entire study were evaluated by the
Ethical Committee of the University of Liege, Belgium and accepted
under the ﬁle numbers 377, 568 and 1074.
2.3. Knockdown of fgfr1a and fgfr2
One to two cell-stage embryos were injected with 4 ng of
antisense morpholino oligonucleotides (MO, Gene Tools Inc.) com-
plementary to the translational start site of fgfr1a (tMOFgfr1: 5′-
GCAGCAGCGTGGTCTTCATTATCAT-3′ (Scholpp et al., 2004) or its 5′
UTR: MOFgfr1a: 5′-CAAAGATCCTCTACATCTGAACTCC-3′ (Thummel
et al., 2006). Splicing morpholinos targeting, respectively the second
or ﬁrst intron's donor splice site in the coding region of fgfr1a (5 ng;
sMOFgfr1a: 5′-ATTCAGTTGCATTCTCACCTGTAAC-3′ (Nakayama et al.,
2008)) or fgfr2 (4 ng; MOFgfr2: 5′-GCTCAAATGTCTTACCTTCAGGTGC-
3′ were also used. Co-injection of tMOFgfr1a and MOFgfr2 was
performed with 2 ng of each morpholino. Morpholinos were diluted
in Danieau buffer and Tetramethylrhodamine dextran (Invitrogen,
Belgium) was added Q4at 0.5% to verify proper injection of the embryos
by ﬂuorescence stereomicroscopy. Standard control morpholino
(MOcon) was injected at the same concentrations. The efﬁcacy of
the sMOFgfr1a splicing morpholino was tested previously by RT-PCR
(Nakayama et al., 2008), while that of sMOFgfr2 was conﬁrmed using
the oligonucleotides Fgfr2-MOtest-F: 5′-CTGCTAATGACCCTGGCAAC-
3′ and Fgfr2-MOtest-R; 5′-AGCTGTCTTTGGTCCAGACG-3′ targeting,
respectively exon 2 and exon 3. Injection of sMOFgfr2 led to alt-
ernative splicing resulting in deletion of 22 nucleotides at the end of
exon 2, thus coding for a truncated and inactive protein (Movie S1,
Fig. S1H). Although no increase of cell death was observed in the
Fgfr1a morphants, in absence or presence of co-injection of a
morpholino directed against p53, this MOp53 was co-injected in all
knockdown experiments to ensure inhibition of MO-induced unspe-
ciﬁc cell death (Robu et al., 2007). The effects of morpholino injection
were tested on at least 150 individuals, performed in at least three
independent experiments.
2.4. Rescue experiments
Human FGFR1 mRNA was synthesized using mMessage mMa-
chine Sp6 Kit (Ambion, TX, USA) from the IMAGE full length cDNA
clone IRATp970D1237D (IMAGE ID: 3896359). The clone was
digested using NotI. 80 pg of FGFR1 mRNA was injected alone or
co-injected with morpholino at the one-cell stage. fgfr2 mRNA was
obtained by digestion of the pZL1-zfgfr2 (ZDB-GENE-030323-1)
clone by BamHI and synthesized using mMessage mMachine
Sp6 Kit. 100 pg/egg of this mRNA were injected alone or with
morpholino directed against Fgf receptors.
2.5. Whole-mount in situ hybridization
Wild type and injected embryos were raised in presence of
0.003% of 1-phenyl-2-thiourea (PTU) until the desired stages, ﬁxed
for 2 h in 4% PFA and dehydrated in 100% methanol for storage at
20 1C. Embryos were rehydrated in PBS and whole mount in situ
hybridization was performed as described and adapted from Dalcq
et al. (in press). Antisense probes were labeled with digoxigenin or
DNP (2,4-dinitrophénol). Anti-digoxigenin-AP was used with NBT/
BCIP for single in situ hybridization; anti-digoxigenin-HRP and
anti-DNP-HRP were used with tyramide-Cy3 (Red) and tyramide-
FITC (green) for the double ﬂuorescent in situ hybridizations
(Perkin-Elmer TSA Kit). The fgfr1a (ZDB-GENE-980526-255) and
fgfr2 (ZDB-GENE-030323-1) riboprobes were prepared from cDNA
clones with Sp6 and T7 RNA polymerase. Other probes used were
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(ZDB-GENE-980526-212) (Akimenko et al., 1994), egr1 (ZDB-
GENE-980526-320) (Close et al., 2002), nkx2.3 (ZDB-GENE-
990415-178) (Lee et al., 1996), runx2b and runx3 (ZDB-GENE-
040629-4 and ZDB-GENE-000605-2) (Flores et al., 2006), sox9a
and sox9b (ZDB-GENE-001103-1 and -2) (Yan et al., 2005; Yan
et al., 2002).
2.6. Alcian blue staining
To observe cartilage at 4 dpf, the embryos were stained with
Alcian blue (Sigma, Bornem, Belgium) as described (Schilling et al.,
1996).
2.7. Acridin orange staining
To detect unspeciﬁc cell death possibly due to morpholino
injection, the treated larvae were exposed to a solution of acridin
orange 5 μg/ml followed by 5 washing steps in E3 and ﬁnally
observation of the ﬂuorescent cells at 502 nm excitation.
2.8. Heatshock conditions
Tg(hsp70l:dnfgfr1-EGFP)pd1 embryos were heat shocked during
30 min at the desired stages by transferring into preheated E3 at
37 1C in a water bath. After that, the embryos were returned to
28 1C until the desired stages were reached. After 24 h, the
embryos were screened for GFP ﬂuorescence to sort transgenic
individuals from their non-transgenic siblings, only strongly ﬂuor-
escent individuals were used for the experiment.
2.9. Immunohistochemistry for MAPK phosphorylation
For immunohistochemistry, embryos were ﬁxed in 2% PFA/
Pipes 0.1 M/MgSO4 1 mM/EGTA 2 mM, pH¼7 over night at 4 1C.
After washing with PBTr 0.3% (PBS with Triton X100 0.3%),
embryos were permeabilized with acetone at 20 1C. Then,
samples were washed 4 times in PBTr 0.3% and endogenous
peroxidases were inhibited during 45 min with PBTr 0.3/H2O2 2%
followed by 4 washes in PBTr 0.3%. Finally, embryos were incu-
bated in PBTr 0.3/4% BSA during 2 h at room temperature followed
by incubation with P-MAPK antibodies 1/2000 in PBTr 0.3/4% BSA





































































































































Fig. 1. fgfr1a is expressed in pharyngeal endoderm beyond 24 hpf. Simple in situ hybridization (ISH) using an fgfr1a probe of wt embryos at 24 (A), 48 (B) and 72 hpf (C);
lateral views, anterior to the left. Single confocal sections of double ﬂuorescent in situ hybridizations for expression of fgfr1a (red) and dlx2a (green) (D) or nkx2.3 (green)
(E) at 24 hpf; sox9a (green) at 43 hpf (F) or nkx2.3 (green) at 48 hpf (G). (G′) confocal projection for nkx2.3 (green) and fgfr1a (red) at 48 hpf in the domain delineated by the
white rectangle in (G). Ventral views, anterior to the right (D–G′). fgfr1a expression is detected in the pharyngeal region (pr), the midbrain/hindbrain boundary (MHB), the
optic stalk (os) and the olfactory placode (op) at 24 hpf (A). fgfr1a mRNA is still observed in brain and in the pharyngeal endoderm (pe) at 48 (B) and 72 hpf (C). In the
pharyngeal region at 24 hpf, fgfr1a (red) expression domains surround those of dlx2a (green) (D), while they overlap with those of nkx2.3 (green) cells in pharyngeal
endoderm (E, yellow arrows). At 43 hpf, no colocalisation is observed between sox9a (green) and fgfr1a (red) (F). fgfr1a (red) continues to coexpressed with nkx2.3 (green) in
endodermal pouches (pe) at 48 hpf (G,G′; yellow arrows). Movies S1–S3: migration stream of cNCC. Scale bar: 150 μm.
A. Larbuisson et al. / Differentiation ∎ (∎∎∎∎) ∎∎∎–∎∎∎ 3
Please cite this article as: Larbuisson, A., et al., Fgf receptors Fgfr1a and Fgfr2 control the function of pharyngeal endoderm in late
cranial cartilage development. Differentiation (2013), http://dx.doi.org/10.1016/j.diff.2013.07.006i
630 min in PBTr 0.3 and incubated 1 h in PBTr 0.3/4% BSA. The
blocking solution was replaced by blocking solution supplemented
with a 500-fold dilution of the secondary antibody from Vectastain
ABC Elite Mouse kit (Vector Laboratories) and incubated over-
night at 4 1C. Then, embryos were washed 6 times for 30 min in
PBTr 0.3. Next, they were incubated 1 h in AþB solutions from
Vectastain Kit (15 μL/mL). After 3 washes of 15 min in PBTr 0.3,
embryos were incubated in ampliﬁcation diluent from TSA Mole-
cular Probe kit (Perkin Elmer) for 5 min. Colorimetric staining was
performed with Tyramide-FITC (1/1000) or Tyramide-Cy3 (1/500)
in ampliﬁcation diluent during 45 min at room temperature in the
dark and, ﬁnally, the embryos were washed 5 times in PBTr 0.3.
2.10. Imaging and analysis
Visible in situ hybridization and Alcian blue pictures were
acquired on a Nikons ECLIPSE 90i microscope using NIS-
Elements microscope imaging software. Fluorescent in situ images
were captured on a Leica TCS SP2 confocal using LCS Leica SP2
software. Pictures and Z-stacks were analyzed with ImageJ; the
same adjustments were used for all pictures from a same
data group.
3. Results
3.1. fgfr1a and fgfr2 are expressed in pharyngeal endoderm.
Zebraﬁsh fgfr1a expression was previously reported in brain,
somites and in the pharyngeal region until 24 h post fertilization
(Rohner et al., 2009; Schilling et al., 1996; Scholpp et al., 2004; Ota
et al., 2010). We conﬁrmed and analyzed more precisely fgfr1a
expression in the pharyngeal region between 24 hpf and 72 hpf by
simple ISH and by double ﬂuorescent ISH with speciﬁc probes for
fgfr1a, dlx2a, nkx2.3 and sox9a. At 24 hpf, fgfr1a expression is
observed in the Midbrain/Hindbrain Boundary (MHB), optic stalk,
olfactory placode and pharyngeal region (Fig. 1A), as expected.
Moreover, fgfr1a mRNA co localized with that for nkx2.3 in
pharyngeal endoderm at 24 hpf (yellow arrows; Fig. 1E; Movie
S1), but scarcely with dlx2a mRNA in cranial neural crest cells
(cNCC) (Fig. 1D; Movie S2); areas of fgfr1a expression in the
pharyngeal region mainly surround those of dlx2a. At 43 hpf, the
sox9a expression domain in cNCC is mainly surrounded by fgfr1a
expression domains in the endodermal pouches (Fig. 1F; Movie S3).
fgfr1a is still expressed at 48 hpf and 72 hpf in brain and in
endodermal tissues (Fig. 1B, C, G, G′). Colocalisation of nkx2.3
and fgfr1a expression at 48 hpf is apparent in endodermal pouches
in the pharyngeal region (yellow arrows; Fig. 1G, G′; Movies S4
and S5).
Expression of fgfr2 is detected in wild type 24 hpf embryos in
hindbrain rhombomers (R1-4), the tectum, the optic stalk and
olfactory placodes and weakly in the pharyngeal region (Fig. 2A).
Expression increases in the pharyngeal region at 26 hpf in the
most posterior arch and was present until 72 hpf (Fig. 2B–D),
while its expression in the brain was maintained during these
developmental stages. At 38 hpf, fgfr2 mRNA was observed in the
same cell type than nkx2.3 i.e. in endodermal pouches of the
pharyngeal region (yellow arrows; Fig. 2E; Movie S6). No coex-
pression of fgfr2 mRNAs was observed with those of sox9a in cNCC
of the pharyngeal region at 72 hpf (Fig. 2G; Movie S8); the fgfr2
expression domains surround those for sox9a and correspond to
pharyngeal endoderm. Double ﬂuorescent ISH using probes for
fgfr1a and fgfr2 conﬁrms co-expression of these two genes in
endodermal pouches and in otic vesicles at 48 hpf (yellow; Fig. 2F;
Movie S7).
In conclusion, both fgfr1a and fgfr2 are predominantly expressed in
cells of the pharyngeal endoderm.
3.2. Viscerocranium cartilage formation requires Fgf signaling
beyond 24 hpf
To determine the importance of Fgf signaling speciﬁcally at
stages beyond 24 hpf, we used Tg(hsp70l:dnfgfr1-EGFP)pd1 trans-
genic embryos which express a dominant-negative Fgfr1 receptor
under the control of the hsp70l heat shock promoter. We per-
formed a heat shock for 30 min at different developmental stages
between 24 and 48 hpf, thereby blocking Fgf signaling in the
entire embryo. The embryos were left to develop until 4 days post
fertilization (dpf) and head cartilage formation was assessed by
alcian blue staining. We observed different phenotypes (Fig. 3A–F),
ranging from close to wild type (type A), mildly affected cartilage
with shortened mandible and hyoid (types B and C) through
increasingly affected viscerocranium with a complete absence of
ceratobranchials, a reduction of Meckel's cartilage and palatoqua-
drate, axis modiﬁcation or absence of ceratohyoid (types D and E)
to ﬁnally only remnants of the neurocranium (type F). Embryos
that underwent heat shock at 26 or 30 hpf presented the highest
proportion (Fig. 3G) of strongly affected cartilage structures. Heat
shock treatments at earlier (before 25 hpf) or later stages (beyond
40 hpf) led to a lower proportion of highly affected larvae. The
extent of MAPK phosphorylation was drastically reduced 15 h after
heat shock treatment both at 24 and at 28 hpf (Movie S1, Fig. S1A–D),
showing that Fgf signaling was similarly reduced in both cases.
Siblings, identiﬁed as non-transgenic by the absence of GFP ﬂuores-
cence formed normal head cartilage after any of the heat shock
treatments, proving that the observed defects are indeed due to
impairment of Fgf signaling by the transgene.
These observations indicate that Fgfr signaling plays a crucial
role for pharyngeal cartilage formation between stages 26 and
40 hpf.
3.3. Both Fgfr1a and Fgfr2 receptors are required for cranial cartilage
formation
To determine the effect of fgfr1a and fgfr2 loss of function, we
assessed cartilage formation in morpholino-injected larvae at
4 dpf by alcian blue staining. Injection of tMOFgfr1a, directed
against the fgfr1 translation initiation codon (Nakayama et al.,
2008) caused an absence of ceratobranchial arches, a strong
reduction of mandible size and inversion of the dorso-ventral axis
of the hyoid in 49% (n¼185/377) of observed individuals (Fig. 4A, B), as
compared to embryos injected with control morpholino (MOcon). No
difference was observed between injection of tMOFgfr1a and co-
injection of a morpholino directed against p53 (MOp53), showing that
the observed defects were not caused by unspeciﬁc apoptosis (not
shown). In addition, no increase of apoptotic or necrotic cells was
observed in the morphants by acridine orange staining, with or
without co-injected MOp53 (not shown). Nevertheless, we performed
all subsequent knock-down experiments by co injecting MOp53. To
further conﬁrm the speciﬁcity of the observed effects for Fgfr1a
depletion, we co-injected tMOFgfr1a and mRNA coding for human
FGFR1 into one-cell stage eggs. At 4 dpf, the proportion of strongly
affected embryos had considerably decreased, whereas 48% (n¼146/
305) of the embryos presented only slight modiﬁcations (Fig. 4C).
For further experiments, the alcian blue stained larvae were
classiﬁed according to their cranial cartilage pattern, from wt
(Type A, Fig. 5A), mildly affected (Fig. 5B), strongly affected head
cartilage but with ceratobranchial arches still present (Fig. 5C),
strongly affected and lacking ceratobranchial arches (Fig. 5D) to
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corresponds to a slightly more intensely stained cartilage and an
abnormal position of the ceratohyals (Fig. 5F). The proportions of
each observed phenotype at the indicated conditions are summar-
ized in the form of a table (Fig. 5G).
Two additional morpholinos targeting fgfr1a mRNA were tested,
one directed against the 5′ UTR region of fgfr1a (5′ UTR MOFgfr1a)
and one splicing morpholino (sMOFgfr1a). Microinjection resulted in
42% and 47% of type D cartilage, respectively for sMOFgfr1a and 5′
UTR MOFgfr1a (Fig. 5G). Microinjection of a splicing morpholino
directed against fgfr2 mRNA (MOFgfr2) resulted in less severe
cartilaginous defects than those injected with MOFgfr1a. Only 16%





































































































































Fig. 2. fgfr2 is expressed in pharyngeal endoderm starting at 26 hpf. Simple in situ hybridization for fgfr2 of wt embryos at 24 hpf (A), 26 hpf (B), 48 hpf (C) and 72 hpf (D).
Lateral views, anterior to the left (A–D). Expression of fgfr2 is detected in the in the optic stalk (os), the olfactory placode (op), in rhombomers 1, 4, 6 (R1-6) and in the optic
tectum (t) at 24 hpf. These expression domains are still observed at 26 hpf and expression starts in the pharyngeal region (pr). fgfr2 mRNA is still expressed in the different
domains of the brain and in pharyngeal endoderm (pe) until 72 hpf (B, C). Confocal section of double ﬂuorescent in situ hybridization for fgfr2 (red) and nkx2.3 (green) reveals
co-expression in endodermal pouches at 38 hpf (E; yellow arrows). At 48 hpf, fgfr1a positive cells co-express fgfr2 in the pharyngeal endoderm (pe) and in the otic vesicle
(ov) (F, yellow). The sox9a expression domain (red) in cartilage (cb) surrounds that of fgfr2 (green) at 72 hpf (G). Scale bar: 150 μm.
A. Larbuisson et al. / Differentiation ∎ (∎∎∎∎) ∎∎∎–∎∎∎ 5
Please cite this article as: Larbuisson, A., et al., Fgf receptors Fgfr1a and Fgfr2 control the function of pharyngeal endoderm in late
cranial cartilage development. Differentiation (2013), http://dx.doi.org/10.1016/j.diff.2013.07.006i
presented a type C head cartilage (Fig. 5G). Evaluation of MAPK
phosphorylation revealed that both tMOFgfr1a and MOFgfr2 injec-
tion lead to a signiﬁcant decrease of Fgf signaling at 30 hpf (Movie
S1, Fig. S1E–G). Co-injection of mRNA coding for zebraﬁsh Fgfr2
together with MOFgfr2 resulted in rescue of the severe defects, with
larvae presenting normal (type A) or mildly affected (type B) head
cartilage. Ectopic expression of either human FGFR1 or zebraﬁsh
Fgfr2 alone generated larvae with normal or mildly affected head
cartilage (type A, B; Fig. 5) or with slightly hypertrophic cartilage
elements (14% and 25%, respectively) (Fig. 5F, G). Co-injection of
tMOFgfr1a and MOFgfr2 generated respectively 52% of type C, 38% of
type D and 12% of type E cartilage. Efﬁcacy of the splicing
morpholinos was veriﬁed by RT-PCR on mRNA from 48 hpf mor-
phants (Movie S1, Fig. S1H). Taken together, these results clearly






































































































































Fig. 4. Knockdown of fgfr1a expression generates cartilage defects at 4 dpf. Ventral view, anterior to the left. Wild type and control MO injected embryos display a normal
growth of the different pieces of pharyngeal cartilage (A). At this stage, Meckel's cartilage (m), palatoquadrate (pq), ceratohyoid (ch), hyosymplectic (hs) and ceratobranchials
(cb1-5) are formed. In tMOFgfr1a morpholino injected embryos, we predominantly observe an absence of the ceratobranchial cartilage, a dorsal modiﬁcation of the axis of
the hyoid and a strong reduction of the mandible (B) (47%). When mRNA for human FGFR1 is coinjected with tMOFgfr1a, all pharyngeal cartilage pieces are restored (C; 38%).
Fig. 3. Inhibition of Fgf signaling beyond 24 hpf perturbs craniofacial cartilage formation. Alcian blue staining at 4 dpf of transgenic Tg(hsp70l:dnFgfr1-eGFP)pd1 embryos
after a heat shock at 37 1C during 30 min starting at the indicated times after fertilization. (A–F) Ventral views, anterior to the left. Six different phenotypes are observed,
ranging from (A) wild type like, all cartilaginous structures are present through (B) all structures are present but reduced in size, (C) all structures are present but a strong
modiﬁcation of the ceratohyoid axis and a reduction of the mandible size is observed, (D) strong modiﬁcations of the ceratohyoid and the mandible and absence of
ceratobranchial arches, (E) remnants of the viscerocranium and defects in the neurocranium to (F) no viscerocranium and strongly affected neurocranium. m: Meckel's
cartilage; pq: palatoquadrate; ch: ceratohyoid; hs: hyosymplectic; n: neurocranium; cb1-5: ceratobranchial 1–5. (G) The proportion of strongly affected cartilage (D–F)
dramatically increases when heat shock is performed between 26 hpf and 30 hpf, while treatment after 40 hpf causes only weak cartilage defects (B, C).
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Fig. 5. Cranial cartilage structures observed in 4 dpf larvae previously injected with fgfr1a and fgfr2 morpholinos and/or mRNA. At this stage, Meckel's cartilage (m),
palatoquadrate (pq), ceratohyoid (ch), hyosymplectic (hs) and ceratobranchials (cb1-5) are formed. Panels A–F illustrate the different cartilage types that were observed in
these experiments, lateral and ventral views, anterior to the left. (A) Wild type and control Mo injected embryos display a normal growth of the different pieces of
pharyngeal cartilage. (B) mildly affected cartilage. (C) strongly affected head cartilage with ceratobranchial arches still present, (D) strongly affected cartilage also lacking
ceratobranchial arches. (E) only remnants of the neurocranium are observed. (F) embryos displaying a stronger staining of cartilage and an abnormal position of the
ceratohyal. (G) table summarizing the proportions of each type of head cartilage pattern observed in the indicated experiments. Column “n” indicates the number of
observed individuals for that particular experiment. Bold numbers indicate the highest proportion of cartilage phenotype in each experiment and red numbers concern the
increased cartilage phenotype.
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To test whether one receptor can rescue depletion of the other,
we co-injected fgfr2 mRNA into tMOFgfr1a morphants, leading to
rescue of the observed defects with a decrease in the proportion of
strongly affected larvae (type D, from 49% to 8%; Fig. 5G) and an
increase of embryos with only slight modiﬁcations of cartilage
structure (type B, from 18% to 66%; Fig. 5G).
3.4. Early neural crest cell differentiation does not require
Fgfr1a and Fgfr2
To investigate the function of fgfr1a and fgfr2 genes in early
differentiation of neural crest cells, we performed ISH on mor-
phants using probes for dlx2a, a marker of migrating and post
migratory cNCCs (Sperber et al., 2008; Akimenko et al., 1994) and
for sox9a, a transcription factor involved in chondrocyte matura-
tion (Yan et al., 2005). In all experiments, the expression patterns
of dlx2a (Fig. 6A–F; Movie S3, Fig. S3) and sox9a (Fig. 6G–L; Movie
S2, Fig. S2; Movie S3, Fig. S3) remained unaffected both in Fgfr1a
and Fgfr2 morphants at 24 and 48 hpf, although a slight decrease
of dlx2a expression was observed at 48 hpf in branchial arches
1 and 2 in both fgfr1a and fgfr2 morpholino-injected embryos
(Fig. 6D–F). Double ﬂuorescent in situ hybridization in control
embryos at 24, 30 and 48 hpf revealed that dlx2a-expressing
cells are intermingled with those expressing sox9a in the phar-
yngeal arches, with patches of cells expressing only one of
these factors neighboring domains of cells expressing both
mRNAs (Movie S3, Fig. S3 A, D, G). Moreover, the expression
and colocalisation domains of sox9a and dlx2a mRNAs are not
affected in fgfr1a or fgfr2 morphants (Movie S3, Fig. S3 A–I)
although a slight reduction of their expression domains is
observed at 48 hpf. Similarly, expression of GFP in ﬂi-GFP trans-
genic embryos was not affected at 48 hpf after injection of
tMOFgfr1a or MOFgfr2, although Fgfr1a knockdown led to pertur-
bations in the branchial arches (Movies S4, Fig. S4). Th.e absence
of substantial modiﬁcations in dlx2a, sox9a and ﬂi1 expression
in morphants suggests that migration of neural crest cells and






































































































































Fig. 6. Fgfr1a and Fgfr2 are not required for dlx2a and sox9a expression. ISH on morphants with probes for dlx2a (A–F) and sox9a (G-M) show no difference of the expression
pattern of these genes compared to control embryos at 24 hpf (A–C, G–I) and at 48 hpf (D–F, J–L), except for a minor modiﬁcation of the dlx2a expression domain (black
arrows; F,G). Anterior is to the left. Ventral views (A–C, G–I) and lateral views (D–F, J–L). Scale bar: 100 μm.
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3.5. Fgfr1a and Fgfr2 are required for condensation and
late differentiation of chondrocytes
Barx1 is a transcription factor involved in condensation of
cranial neural crest cells whose expression was shown to be
controlled by Fgf signaling (Sperber and Dawid, 2008). Moreover,
barx1 expression is essential for runx2b expression, a transcrip-
tion factor absolutely required for chondrocyte maturation (Flores
et al., 2006; Flores et al., 2004) in the pharyngeal region. At 48 hpf,
barx1 mRNA is detected in chondrocytes of the ceratobranchial
arches, the hyosymplectic and the ceratohyal in control embryos
(Fig. 7A) (Sperber and Dawid, 2008). At this stage, fgfr1a or fgfr2
knock-down caused a reduction of barx1 expression, to different
extents (Fig. 7B, E).
At 48 hpf, runx2b mRNAs are observed in the mandible, the
hyoid, the ceratobranchial arches, the ethmoid plate and in the
cleithrum (Fig. 8A). In Fgfr1a or Fgfr2 morphants, all runx2b





































































































































Fig. 7. barx1 expression is down-regulated in Fgfr1a and Fgfr2 morphants at 48 hpf. In control embryos at 48 hpf, barx1 transcripts are detected in chondrocytes of the
ceratobranchial arches (cb1-5), the ceratohyoid (ch), the hyosympletic (hs) and in the mandibular zone (A). Depletion of Fgfr1a leads to a dramatic decrease of barx1
expression in the ceratobranchial chondrocytes (B), while a more modest decrease is observed in Fgfr2 morphants in the pharyngeal region (E) compared to control. runx3
mRNA injection does not affect the barx1 expression pattern (D). Co-injection of runx3 mRNA with tMOFgfr1a or MOFgfr2 restores wild type expression of barx1 (C, F) in
100% of morphants. Ventral views, anterior to left. Scale bar: 100 μm.
Fig. 8. Transcription of the runx2b gene is decreased in Fgfr1a and Fgfr2 morphants. Lateral views of in situ hybridizations, anterior to the left. At 48 hpf, runx2b expression in
absence of fgfr1a is observed only in the cleithrum (cl) (B,C), while in control embryos runx2b transcripts are detected in the mandible (ma), in the ceratohyoid (ch), in the
hyosympletic (hs), in ceratobranchials (cb1-5) and in the ethmoid plate (ep) (A,F). Ectopic expression of FGFR1 mRNA in morphants for Fgfr1a restores runx2b expression in
the pharyngeal cartilages (D, 61% n¼149/245), similar to co-injection of tMOFgfr1a and fgfr2 mRNA (E, 67% n¼131/196). In Fgfr2 morphants, runx2b expression persists only
in the cleithrum (G,H). Co-injection of FGFR1 mRNA and MOFgfr2 restores wild type runx2b expression in 61% (n¼134/220) of the embryos (I) and 65% (n¼172/264) of
embryos have a wild type runx2b expression pattern when morpholino against fgfr2 is co injected with fgfr2 mRNA (J). Scale bar: 100 μm.
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for its expression in the cleithrum (Fig. 8B–D). Rescue experiments
reveal that co-injection of tMOFgfr1a with human FGFR1 mRNA or
zebraﬁsh fgfr2 restores wild type runx2b expression in 61%
(n¼149/245) and 67% (n¼131/196) of the larvae, respectively
(Fig. 8E, F). Similarly, MOFgfr2-injected embryos recover expres-
sion of runx2b in the pharyngeal region when FGFR1 mRNA or
mRNA fgfr2 is co-injected, respectively in 61% (n¼134/220) and
65% (n¼172/264) of injected embryos (Fig. 8G, H). These data
suggest that the two receptors are involved in condensation and
late maturation of chondrocytes.
3.6. Fgfr1a and Fgfr2 are not essential for formation
of the endodermal pouches
To determine the function of the two receptors in endodermal
pouch formation, we performed in situ hybridization with the
endodermal marker nkx2.3 (Lee et al., 1996) on both morphants. At
24 and 48 hpf and in comparison with control embryos, loss of
function of fgfr1a or fgfr2 does not affect nkx2.3 expression, only a
modiﬁcation of the endodermal pouch patterning was observed in
the ceratobranchial 5 (cb5) region (arrows; Fig. 9E, F) at 48 hpf. We
also observed that Fgfr1a depletion does not affect fgfr2 expression
and conversely Fgfr2 depletion does not affect fgfr1a expression in
the pharyngeal endoderm at 48 hpf (Fig. 10). Similarly, injection of
both morpholinos into sox17-GFP (Sakaguchi et al., 2006) trans-
genic embryos revealed that expression of this endodermal
marker is maintained, albeit again displaying an aberrant pattern-
ing of the cb5 pouches at 48 hpf (Moive S5, Fig. S5 B, C).
These results suggest that both Fgfr1a and Fgfr2 are not
required for formation of the pharyngeal endoderm, but contri-
bute to its correct shaping at 48 hpf.
3.7. Fgfr1a and Fgfr2 activate the Runx3–Egr1–Sox9b–fsta cascade
in pharyngeal endoderm
Recently, a regulatory cascade was described in zebraﬁsh
pharyngeal endoderm involving the transcription factors Runx3–
Egr1–Sox9b (Dalcq et al., in press) that inhibits expression of
Follistatin A, a BMP inhibitor. This down-regulation allows the full
activity of BMP signaling required for expression of runx2b in
cartilage mesenchyme. We investigated the effect of Fgfr1a or
Fgfr2 depletion on this cascade.
In control embryos, runx3 expression was observed at 48 hpf in
pharyngeal endoderm, the cleithrum and the trigeminal ganglion
(Fig. 11A, C), as expected (Flores et al., 2006). Knockdown of each
receptor decreases runx3 expression in the pharyngeal endoderm
(Fig. 11B, D), while its expression in the cleithrum and in the
trigeminal ganglia is still present. This effect is speciﬁc, as co-
injection of MOFgfr2 with fgfr2 or human FGFR1 mRNA caused
respectively 87% (n¼47/54) or 85% (n¼59/70) of larvae to recover
runx3 expression in the pharyngeal endoderm.
At 72 hpf, egr1 expression can be detected in oral epithelium, in
the brain and in the pharyngeal endoderm of control embryos
(Fig. 11G, I). Fgfr1a and Fgfr2 morphants showed an absence of
egr1 expression in the pharyngeal endoderm whereas the other
expression domains remain unchanged (Fig. 11H, J).
At 48 hpf, sox9b mRNA is localized in pharyngeal endoderm, in
the hindbrain, in the tectum and in the pectoral ﬁn bud in control
embryos (Fig. 11K, M) (Yan et al., 2005). In situ hybridizations
indicate that Fgfr1a or Fgfr2 knock down leads to an absence of
sox9b expression in the endodermal pouches (Fig. 11 L,N) and a
decrease in the mandibular and hyoid region, whereas expression
in the hindbrain is maintained.
Sox9b was shown to repress expression of the secreted BMP
inhibitor follistatin A in pharyngeal endoderm, thereby allowing
correct BMP signaling to the developing chondrocytes (Dalcq et al.,
in press). In control embryos, we observed weak fsta expression in
the pharyngeal region at 48 hpf (Fig. 11O, Q), while fsta transcrip-
tion was strongly upregulated when tMOFgfr1a or MOFgfr2 were
injected into one-cell stage embryos (Fig. 11P, R).
To further support the involvement of Fgfr1a and Fgfr2 recep-
tors in activation of the endodermal regulatory cascade, we tested
whether ectopic expression of Egr1 or Runx3 would be able to
rescue the cartilage defects in Fgfr morphants. Injection of either
egr1 or runx3 mRNA together with tMOFgfr1a or MOFgfr2 resulted
in a drastic decrease of the severe phenotypes observed in Fgfr
morphants (table in Fig. 5G). In 48 hpf embryos, co-injection of
runx3 mRNA with tMOFgfr1a resulted in partial (43%, n¼57/133)
or near complete (52%, n¼69/133) rescue of runx2b expression





































































































































Fig. 9. Endodermal expression of nkx2.3 is maintained in the pharyngeal region upon Fgfr1a and Fgfr2 knock-down. In both Fgfr1a and Fgfr2 morphants, nkx2.3 expression is
still observed in the pharyngeal region at 24 hpf and 48 hpf. However, nkx2.3 patterning is modiﬁed in the ceratobranchial 5 region (E, F; arrows) at 48 hpf. Ventral views,
anterior to the left. pe: pharyngeal endoderm. Scale bar: 100 μm.
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or completely (62%, n¼71/115) rescued Fgfr2 knockdown, while
injection of runx3 mRNA alone had no effect (Fig. 12E–H). Simi-
larly, injection of runx3 mRNA rescued the loss of barx1 expression
caused by tMOFgfr1a (100% rescue, n¼48/48) or MOFgfr2 (100%
rescue, n¼64/64)(Fig. 7C, F).
These results show that in pharyngeal endoderm, both Fgfr1a and
Fgfr2 control the endodermal cascade involved in chondrogenesis.
4. Discussion
4.1. The receptors Fgfr1a and Fgfr2 are required for late
differentiation of pharyngeal chondrocytes
The development of head cartilage, deriving from cranial neural
crest cells and forming the matrix for subsequent endochondral
bone formation, depends on a complex and precisely controlled
interplay between different extracellular signaling pathways.
Among these, Fgf signaling has been extensively studied in
zebraﬁsh. Fgf3 and Fgf8 ligands produced in the hindbrain and
lateral mesoderm are required during early segmentation stages
for correct organization of the endodermal pouches (Crump et al.,
2004). Later, Fgf signaling is required in cNCCs for their conversion
into the ectomesenchymal lineage, characterized by dlx2a expres-
sion, after migration into the endodermal pouches (Blentic et al.,
2008). Endodermal expression of fgf3 is required for dlx2a expres-
sion in post migratory cNCCs and their survival in the posterior
arches (David et al., 2002; Nissen et al., 2003), while loss of
function of both fgf3 and fgf8 affect differentiation and survival of
cNCCs as well as dlx2a expression in all the arches (Crump et al.,
2004; Walshe and Mason, 2003). Thus, Fgf signaling acts during
segmentation stages before 24 hpf on pharyngeal cartilage forma-
tion through cell-autonomous mechanisms within cNCC-derived
chondrocyte precursors and indirectly through patterning of the
pharyngeal endoderm.
In this study, we examined the role of Fgf signaling during
craniofacial cartilage formation using the transgenic line Tg
(hsp70l:dnfgfr1-EGFP)pd1 which allows controlled expression of a
dominant negative Fgf receptor mutant (Ota et al., 2010). We show
an additional function for Fgf signaling at later stages in chon-
drogenesis, which is most effective after 30 hpf compared to
earlier (24–26 hpf) or later (beyond 40 hpf) stages. At this stage,
conversion of cNCCs to ectomesenchyme is ﬁnished and the ﬁrst
steps of chondrocyte differentiation, such as sox9a expression, are
initiated.
As the dominant negative receptor blocks signaling by inter-
acting with endogenous receptors in the cells where it is
expressed, we decided to study the role of Fgfr1a and Fgfr2
receptors by antisense morpholino injection, as both were pre-
viously shown to be expressed in the pharyngeal region at 24 hpf
(Tonou-Fujimori et al., 2002; Ota et al., 2010). Depletion of each
Fgfr1a or Fgfr2 leads to severe defects in cranial cartilage forma-
tion, similar to those observed upon Fgf inhibition after 24 hpf.
Efﬁcacy of the splicing morpholinos was veriﬁed by RT-PCR, while
unspeciﬁc effects due to morpholino injection were excluded by
co-injecting a morpholino against p53 to block unspeciﬁc apop-
tosis (Robu et al., 2007) in all experiments. Results obtained in the
presence of MOp53 were similar to those obtained without co-
injection (data not shown). In addition, we tested three different
morpholinos directed against fgfr1a with similar results and we
show that the defects caused by depletion of each receptor are





































































































































Fig. 10. No mutual regulation between fgfr1a and fgfr2 in the pharyngeal region. Lateral view of in situ hybridization, anterior is to the left. At 48 hpf, Fgfr2 knock down does
not affect fgfr1a expression in the pharyngeal endoderm (pe), mandible region (m) and hyoid region (h) (B) compared to control embryos (A). Similarly, fgfr2 expression is
still observed at 48 hpf (D) in pharyngeal endoderm (pe), mandibular and hyoid region (m, h), hindbrain (hb) and ethmoid placode (ep) in control and Fgfr1a morphants
embryos. Scale bar: 100 μm.
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ectopic expression of the receptors alone led to either no defect or
an increase in cartilage formation.
When we investigated the effect of receptor depletion on
chondrocyte differentiation, we observed that expression of dlx2a
and of sox9a is maintained at 24 and 48 hpf. By double ﬂuorescent
in situ hybridization at 24, 30 and 48 hpf, we observed three types
of domains within the ectomesenchymal condensations: one
domain mostly consisting of cells expressing both dlx2a and sox9a,
the other two formed of cells expressing either dlx2a or sox9a. One
possible explanation for this observation would be that cells
expressing ﬁrst dlx2a only subsequently differentiate into cells
expressing both factors and ﬁnally into sox9a-only expressing
cells. Importantly, we did not observe a substantial modiﬁcation
of this combined expression pattern in Fgf receptor morp-
hants, suggesting an absence of effect on developmental timing.
In contrast, expression of the late chondrocyte marker runx2b was
completely abolished in the pharyngeal arches, indicating that
cNCC formation, migration and early differentiation are not
affected, while late maturation is absent.
In addition, we observe a decreased expression of barx1 in the
pharyngeal arches of both Fgfr1a and Fgfr2 morphants. In mouse,
Barx1 is expressed in cranio-facial ectomesenchyme and the
stomach (Tissier-Seta et al., 1995), it is required for differentiation
of the stomach epithelium by controlling expression of Wnt
signaling inhibitors and for spleen morphogenesis (Woo et al.,
2011). In zebraﬁsh, barx1 expression was observed in a subset of
cNCC at 19 hpf, in the three streams of cranial neural crest at
24 hpf and in developing ectomesenchyme at later stages (Sperber
and Dawid, 2008). Its expression was abolished in the presence





































































































































Fig. 11. Fgfr1a or Fgfr2 knockdown leads to decreased expression of runx3, egr1 and sox9b in the pharyngeal endoderm. Lateral view, anterior to the left. At 48 hpf, runx3
expression in the pharyngeal endoderm (pe) is absent in Fgfr1a and Fgfr2 morphants, whereas its expression is still observed in the cleithrum (cl), the pectoral ﬁn (pf) and in
the trigeminal ganglia (tg) (B, D). Co-injection of FGFR1 mRNA with morpholino against Fgfr2 restores runx3 expression in pharyngeal endoderm at 48 hpf (E, n¼59/70).
Similarly, runx3 mRNA expression is restored when fgfr2 mRNA is co-injected with MOFgfr2 (F, n¼47/54). At 72 hpf in both Fgfr1a and Fgfr2 morphants, egr1 expression is
absent in the pharyngeal endoderm (pe), while its expression is still present in the different parts of the brain (H,J) compared to control embryos (G, I). Compared to control
embryos (K, M), the endodermal marker sox9b is absent in the pharyngeal endoderm of the ceratobranchial region at 48 hpf when Fgfr1a or Fgfr2 are downregulated (L, N).
Moreover, sox9b expression is reduced in the mandibular (m) and hyoid region (h) in both receptor morphants (L, N). At 48 hpf, fsta expression in the pharyngeal endoderm
is upregulated in fgfr1a and fgfr2 morphants (P, R) compared to injected control embryos (O, Q). Scale bar: 100 μm.
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deﬁciency in prechondrocyte aggregation and various defects in
formation of the different pharyngeal cartilage elements. Expres-
sion of dlx2a and sox9a was maintained while runx2b expression
was decreased. Barx1 was also shown to promote cartilage fate
versus joints formation in the head (Nichols et al., 2013). Together
with these observations, our results suggest that Barx1 is part of a
regulatory cascade in developing chondrocytes required for
expression of runx2b and subsequent maturation.
4.2. Fgfr1a and Fgfr2 control the function of pharyngeal endoderm
in head cartilage formation
At this point, it was important to determine the precise tissues
that express these Fgf receptors at the stages beyond 24 hpf. We
show that both Fgfr1a and Fgfr2 receptors are expressed in
pharyngeal endoderm by double ﬂuorescent in situ hybridization
revealing their coexpression with the endodermal marker nkx2.3,
while their expression domains are clearly distinct from those of
cNCC markers such as dlx2a or sox9a. We further show that fgfr1a
and fgfr2 expression largely overlaps in pharyngeal endoderm at
48 hpf. This is consistent with the previously described expression
for fgfr1a in the pharyngeal arches (Ota et al., 2010) and fgfr2 in
axial mesoderm and endoderm at 24 hpf (Tonou-Fujimori et al.,
2002). In our experiments, fgfr2 mRNA was weakly detected in the
pharyngeal region at 24 hpf, but clearly observed at 26 hpf,
suggesting that its endodermal expression starts around this stage.
With the observed timing of the requirement for Fgf signaling
around 30 hpf, this observation could explain the somewhat
weaker effects observed upon Fgfr2 depletion. Earlier requirement
for Fgf signaling in cNCCs during segmentation (Blentic et al.,
2008) suggests the presence of an Fgf receptor at this stage in
cNCCs, however the exact nature of this receptor was not
determined.
Our loss of function studies reveal that both receptors act on
the function of pharyngeal endoderm during chondrogenesis.
Formation and initial patterning of pharyngeal pouches is not
affected, as shown by the intact expression patterns of nkx2.3 and
sox17. Only a slight defect is observed at 48 hpf in segmentation of
the most posterior pouch, which might arise as a secondary effect
due to the defects in cNCC differentiation. In contrast, expression
of later markers of endodermal pouches, such as runx3, egr1 and
sox9b is severely reduced, indicating that the function of the
mature endodermal pouches is abolished. Expression of the three
transcription factors Runx3, Egr1 and Sox9b was recently shown to
be required in pharyngeal endoderm to reduce expression of fsta,
coding for the BMP inhibitor follistatin A (Dalcq et al., in press).
Consistent with this model, we observed a clear increase of fsta
expression in Fgfr1a and Fgfr2 morphants. Furthermore, the
defects observed in our receptor morphants could be rescued by
expression of exogenous Runx3 or Egr1, indicating that the loss of
this endodermal regulatory cascade is the major cause for cartilage
defects in Fgfr1a or Fgfr2 morphants. Taken together, these
observations suggest that the two Fgf receptors are required to
initiate the regulatory cascade in pharyngeal endoderm that
controls expression of fsta, and thus allows correct BMP signaling
to the cNCC.
The various Fgf ligands bind to the different receptors with
speciﬁc afﬁnities and further variation is brought about by the
presence of different splicing isoforms for Fgfr1, 2 and 3 (Zhang
et al., 2006; Ornitz et al., 1996). Using the human FGFR isoforms, it
appears that the two major Fgfs involved in cartilage formation,
Fgf3 and Fgf8 are able to bind to at least one isoform of each
receptor 1 or 2. The fact that loss of function of each Fgfr1a or
Fgfr2 results in cartilage defects points at a non-redundant,
speciﬁc function for each receptor, which could be brought about
by speciﬁcity for a particular ligand or speciﬁcity in downstream
signaling for each receptor. Our results showing that the defects
caused by lack of one receptor can be rescued by expression of the
other argue against such speciﬁcity. We also show that knockdown
of one receptor does not affect expression of the other. Although
we cannot completely rule out rescue of speciﬁc functions of one
receptor by exogenous over expression of the other, we favor the
explanation of a requirement for a precise amount of receptors to
ensure activation of the regulatory cascade. Further support for
this interpretation comes from the similarity of the defects
observed upon knockdown of each receptor.
Considering the importance of Fgf signaling for the entire devel-





































































































































Fig. 12. Co-injection of runx3 mRNA rescues the defects in tMOFgfr1 and MOFgfr2 morphants. Lateral views of in situ hybridizations, anterior to the left. At 48 hpf, runx2b
expression is detected in the mandible (ma), in the ceratohyoid (ch), in the hyosympletic (hs), in ceratobranchials (cb1-5) and in the ethmoid plate (ep) (A, F) in control
embryos, while it is only observed in the cleithrum (cl) in Fgfr1a or Fgfr2 morphants (B, E). Ectopic expression of runx3 mRNA in Fgfr1a morphants restores expression of
runx2b in the pharyngeal cartilages partially in 43% (n¼57/133) of embryos (C) and completely in 52% (n¼69/133) of injected embryos (D). Co-injection of runx3 mRNA and
MOFgfr2 restores wild type runx2b expression in 62% (n¼71/115) of embryos (G), while 33% (n¼38/115) of embryos present a decreased expression of runx2b (F). Injection of
runx3 mRNA alone does not affect runx2b expression in injected embryos (H). Scale bar: 100 μm.
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formation of the pharyngeal arches (Blentic et al., 2008; Crump et al.,
2004), it seems surprising that the effects of fgfr1a or fgfr2 knockdown
are not more severe. Indeed, the general morphology of the mor-
phants was not much affected, brain segmentation was normal,
patterning of the pharyngeal endoderm was close to normal and
the ﬁrst markers for chondrocyte differentiation are present. This is in
sharp contrast to the defects observed upon complete Fgf inhibition
during segmentation (Crump et al., 2004). Assuming that knockdown
of the receptors is probably not complete in our experiments, these
observations indicate that the requirement for Fgfr1a and Fgfr2
during these early stages is less stringent and/or that their absence
is more efﬁciently compensated by other members of the Fgfr family,
such as Fgfr3.
In conclusion (Fig. 13), we show that Fgf receptors Fgfr1a and
Fgfr2 are expressed in zebraﬁsh endodermal pouches beyond
24 hpf, where they are required to ensure activation of a regula-
tory cascade in pharyngeal endoderm. This cascade reduces
expression of the BMP antagonist fsta, thereby allowing full
activity of BMP signaling in the pharyngeal region to induce
chondrocyte maturation in head cartilage.
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Fig. 13. Fgfr1a and Fgfr2 activate a regulatory cascade required to modulate Bmp-
signaling during cranial cartilage development in zebraﬁsh. Signaling model
describing the regulatory cascades in pharyngeal endoderm and cNCCs. Fgf
signaling through Fgfr1a and Fgfr2 present in pharyngeal endoderm initiate a
regulatory cascade composed of the three transcription factors Runx3, Egr1 and
Sox9b, which down-regulates fsta expression coding for a Bmp antagonist. This
down-regulation allows Bmp ligands to bind to their receptor and induce runx2b
expression in cranial neural crest cells (cNCC).
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